January Therapeutics

January Therapeutics is developing next generation targeted anti-cancer therapies. Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of known drugs, January is developing unique chemical matter to leverage well established anti-cancer mechanisms of action while adding new cancer targeting properties. Our goal is to create novel drugs with superior efficacy and reduced toxicity in hard-to-treat malignancies with initial application in advanced pancreatic, lung, and ovarian cancers.